Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.

Autor: Bousset, Laura^1,2 (AUTHOR), Septier, Amandine^1,2 (AUTHOR), Bunay, Julio^1,2 (AUTHOR), Voisin, Allison¹ (AUTHOR), Guiton, Rachel¹ (AUTHOR), Damon-Soubeyrant, Christelle¹ (AUTHOR), Renaud, Yoan¹ (AUTHOR), De Haze, Angélique¹ (AUTHOR), Sapin, Vincent¹ (AUTHOR), Fogli, Anne¹ (AUTHOR), Rambur, Amandine^1,2 (AUTHOR), De Joussineau, Cyrille^1,2 (AUTHOR), Kocer, Ayhan^1,2 (AUTHOR), Trousson, Amalia^1,2 (AUTHOR), Henry-Berger, Joëlle¹ (AUTHOR), Höring, Marcus³ (AUTHOR), Liebisch, Gerhard³ (AUTHOR), Matysik, Silke³ (AUTHOR), Lobaccaro, Jean-Marc A.^1,2 (AUTHOR), Morel, Laurent^1,2 (AUTHOR)

Publikováno v: PLoS Biology. 12/7/2020, Vol. 18 Issue 12, p1-25. 25p. 5 Color Photographs, 2 Graphs.

Prostate cancer and castration resistance mechanisms : analysis of the role of nuclear receptors LXRs

Autor: Bousset, Laura

Publikováno v: Génétique. Université Clermont Auvergne [2017-2020], 2019. Français. ⟨NNT : 2019CLFAS016⟩

Androgen deprivation therapy remains the gold standard treatment for advanced prostate cancer. Unfortunately, most of the patients who initially respond to androgen deprivation therapy, later experience tumor relapse, which inevitably progresses to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::402f30f7dd1ce56407e890804592ea73
https://tel.archives-ouvertes.fr/tel-03132200/file/2019CLFAS016_BOUSSET.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.